NEURAXON
NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.
NEURAXON
Industry:
Biotechnology Neuroscience Therapeutics
Founded:
2004-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.neuraxon.com
Total Employee:
11+
Status:
Active
Contact:
416-673-6697
Total Funding:
57.41 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region Microsoft Word
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
BDC Venture Capital
BDC Venture Capital investment in Debt Financing - NeurAxon
Delphi Ventures
Delphi Ventures investment in Debt Financing - NeurAxon
Ventures West
Ventures West investment in Debt Financing - NeurAxon
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Debt Financing - NeurAxon
H.I.G. Capital
H.I.G. Capital investment in Debt Financing - NeurAxon
Lawrence Bloch
Lawrence Bloch investment in Debt Financing - NeurAxon
The Ontario Capital Growth
The Ontario Capital Growth investment in Debt Financing - NeurAxon
OrbiMed
OrbiMed investment in Debt Financing - NeurAxon
NeuroVentures
NeuroVentures investment in Debt Financing - NeurAxon
NeuroVentures
NeuroVentures investment in Series B - NeurAxon
Newest Events participated
Participated in NeuroTech Ontario Showcase & Public Talk
on 2016-09-27 as exhibitor
Official Site Inspections
http://www.neuraxon.com
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "NeurAxon"
NeurAxon - Crunchbase Company Profile & Funding
Dec 30, 2009 · NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, …See details»
NeurAxon Inc. | BDC.ca
NeurAxon is a leader in discovering and developing next-generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating …See details»
Organization | NeurAxon Inc.
NeurAxon Inc. Report issue For profit Phase 2 Founded: Toronto ON Canada (2004)See details»
NeurAxon Inc - LinkedIn
NeurAxon Inc. is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of the neuronal nitric oxide synthase (nNOS) enzyme, an enzyme …See details»
NeurAxon Inc Company Profile | Mississauga, ON, Canada
Find company research, competitor information, contact details & financial data for NeurAxon Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»
NeurAxon Inc - Company Profile and News - Bloomberg Markets
NeurAxon Inc. operates as a biopharmaceutical company. The Company discovers and develops pain therapeutics targeting neuronal nitric oxide synthase, an enzyme involved in modulating …See details»
NeurAxon Pharma - PitchBook
Developer of pain therapeutics using selective inhibitors of nitric oxide synthase. The company develops oral products in pipeline addressing acute migraine, neuropathic pain, chronic daily headache, inflammatory pain, migraine …See details»
NeurAxon Inc: Contact Details and Business Profile
NeurAxon Inc. is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of the neuronal nitric oxide synthase (nNOS) enzyme, an enzyme …See details»
NeurAxon - Products, Competitors, Financials, Employees, …
NeurAxon is discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain …See details»
NeurAxon Pharma Company Profile - Office Locations, …
See insights on NeurAxon Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Neuraxon - Crunchbase Company Profile & Funding
Neuraxon is a distributor of medical devices for neurology, neurosurgery, and cardiology needs.See details»
Neuraxon - Products, Competitors, Financials, Employees, …
Neuraxon provides solutions for treating brain disorders within the medical sector. Use the CB Insights Platform to explore Neuraxon's full profile.See details»
NeurAxon - Contacts, Employees, Board Members, Advisors
NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.See details»
NeurAxon Pharma - Company Profile - Tracxn
Nov 5, 2024 · NeurAxon Pharma - Developer of NOS inhibiting small molecules for neuropathies. Raised a total funding of $53.2M over 8 rounds from 13 investors. NeurAxon Pharma has 287 …See details»
NeurAxon - Products, Competitors, Financials, Employees, …
NeurAxon Inc. Use the CB Insights Platform to explore NeurAxon's full profile. NeurAxon - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
NeurAxon Pharma - Overview, News & Similar companies
View NeurAxon Pharma (www.neuraxon.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Knight Therapeutics Inc. and NeurAxon Inc. Form Partnership for …
Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, today announced that it has entered into a strategic partnership with NeurAxon Inc. for the …See details»
Knight Therapeutics Inc. and NeurAxon Inc. Form Partnership for …
Jan 1, 2015 · NeurAxon is the first company to develop selective inhibitors of NOS and has a unique patent portfolio to protect its proprietary knowledge. NeurAxon Pharma will focus on …See details»
NeurAxon Series B Garners $32M For nNOS Pain Drugs
Aug 21, 2007 · In one of the larger U.S.-led Series B rounds, NeurAxon Inc. raised $32 million for its approach to pain drugs that targets neuronal nitric oxide synthase (nNOS), with the lead …See details»
NeurAxon Closes a Convertible Debt Financing Deal - Venture …
Sep 29, 2010 · NeurAxon Inc. closed a convertible debt financing. The Canadian developer of next-generation pain therapeutics said the debt can be exchanged for class B preferred …See details»